These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 194838)

  • 1. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.
    Moller-Larsen A; Heron I; Haahr S
    Infect Immun; 1977 Apr; 16(1):43-7. PubMed ID: 194838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease.
    Russell AS; Essery G
    Cancer; 1977 Jul; 40(1):42-5. PubMed ID: 195708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1.
    Heron I; Moller-Larsen A; Berg K
    Infect Immun; 1977 Apr; 16(1):48-53. PubMed ID: 194839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.
    Subramanian T; Rawls WE
    J Clin Microbiol; 1977 Jun; 5(6):551-8. PubMed ID: 195975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.
    Ching C; Lopez C
    Infect Immun; 1979 Oct; 26(1):49-56. PubMed ID: 227799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.
    Russell AS; Kaiser JT
    J Allergy Clin Immunol; 1976 Nov; 58(5):539-45. PubMed ID: 185242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
    J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.
    Russell AS; Percy JS; Kovithavongs T
    Infect Immun; 1975 Feb; 11(2):355-9. PubMed ID: 163220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
    Shore SL; Melewicz FM; Gordon DS
    J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed herpes simplex type 1-infected cells as antigen for in vitro lymphocyte proliferation.
    Welling-Wester S; Huitema BA; Wilterdink JB
    J Immunol Methods; 1985 Feb; 76(2):239-46. PubMed ID: 2982955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.
    Kohl S; Drath DB; Loo LS
    Infect Immun; 1982 Dec; 38(3):1231-41. PubMed ID: 6295943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    Melewicz FM; Shore SL; Ades EW; Phillips DJ
    J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
    Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
    J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
    Santoli D; Trinchieri G; Lief FS
    J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune destruction of virus-infected cells early in the infectious cycle.
    Shore SL; Cromeans TL; Romano TJ
    Nature; 1976 Aug; 262(5570):695-6. PubMed ID: 183139
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysis of herpes simplex virus (HSV) infected targets. I. A comparison of the activity of lymphocytes from patients with HSV recurrences at different anatomical sites.
    Hendricks RL; Sugar J
    Curr Eye Res; 1984 Mar; 3(3):473-80. PubMed ID: 6321105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complement.
    Cromeans TL; Shore SL
    Infect Immun; 1981 Mar; 31(3):1054-61. PubMed ID: 6262246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.
    Rola-Pleszczynski M
    J Immunol; 1980 Oct; 125(4):1475-80. PubMed ID: 6967905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
    J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.